Gelonghui, May 14 | Hongbo Pharmaceutical rose and stopped 20CM, Haite Biotech rose more than 10%, while Pharmaceutical Stone Technology, Chengdu Pioneer, Pharmaceutical Ming Kangde, and Dizhe Pharmaceutical were ahead of the curve. According to reports, according to reports, a recent study from BCG (Boston Consulting) found that the success rate of AI-generated drug molecules in phase I clinical trials was as high as 80%-90%, while the historical average was about 50%. In just under a year, AI has predicted the structural universe of 200 million proteins.
A股创新药板块反弹 泓博医药20CM涨停
The A-share innovative drug sector rebounded, and Hongbo Pharmaceutical's 20CM rose and stopped
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.